Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey Guss

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Journal of Palliative Medicine|March 14, 2022
Top Ten Tips Palliative Care Clinicians Should Know About Psychedelic-Assisted Therapy in the Context of Serious IllnessWilliam E Rosa, Zachary Sager, Megan Miller, et al.
Chembiochem : a European Journal of Chemical Biology|September 25, 2020
Characterization of Apo-Form Selective Inhibition of Indoleamine 2,3-Dioxygenase*Rodrigo F Ortiz-Meoz, Liping Wang, Rosalie Matico, et al.
Bioorganic & Medicinal Chemistry Letters|July 27, 2013
The discovery of potent blockers of the canonical transient receptor channels, TRPC3 and TRPC6, based on an anilino-thiazole pharmacophoreDavid G Washburn, Dennis A Holt, Jason Dodson, et al.
Nature|November 9, 2018
Design of amidobenzimidazole STING receptor agonists with systemic activityJoshi M Ramanjulu, G Scott Pesiridis, Jingsong Yang, et al.
Nature|May 31, 2019
Author Correction: Design of amidobenzimidazole STING receptor agonists with systemic activityJoshi M Ramanjulu, G Scott Pesiridis, Jingsong Yang, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Journal of Palliative Medicine|March 14, 2022
Top Ten Tips Palliative Care Clinicians Should Know About Psychedelic-Assisted Therapy in the Context of Serious IllnessWilliam E Rosa, Zachary Sager, Megan Miller, et al.
Chembiochem : a European Journal of Chemical Biology|September 25, 2020
Characterization of Apo-Form Selective Inhibition of Indoleamine 2,3-Dioxygenase*Rodrigo F Ortiz-Meoz, Liping Wang, Rosalie Matico, et al.
Bioorganic & Medicinal Chemistry Letters|July 27, 2013
The discovery of potent blockers of the canonical transient receptor channels, TRPC3 and TRPC6, based on an anilino-thiazole pharmacophoreDavid G Washburn, Dennis A Holt, Jason Dodson, et al.
Nature|November 9, 2018
Design of amidobenzimidazole STING receptor agonists with systemic activityJoshi M Ramanjulu, G Scott Pesiridis, Jingsong Yang, et al.
Nature|May 31, 2019
Author Correction: Design of amidobenzimidazole STING receptor agonists with systemic activityJoshi M Ramanjulu, G Scott Pesiridis, Jingsong Yang, et al.
Pageof 2